SAN FRANCISCO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019 and to its Top 10 Most Innovative Companies in Biotech. Velano was recognized for its innovative approach to reimagining the status quo in medicine by removing the needle from blood collection.
More than one billion inpatient blood draws occur around the world every year, informing nearly 70% of all medical decisions. Yet this procedure is made more difficult and less efficient through the use of needles, a process that is further complicated by the rising incidence of Difficult Venous Access (DVA) patients due to age, obesity and chronic illness.
Velano’s award-winning PIVO™ needle-free blood collection device and its family of vascular access products combat the urgent challenge of vascular access globally through a new, more humane standard of care. Co-founded by a physician inventor and a chronic disease patient with a clinical fear of needles in 2012, Velano has expanded its one-stick hospitalization aim to dozens of U.S. hospitals and touched hundreds of thousands of lives in 2018 alone.
“Transforming the status quo and delivering a more humane standard of care is finding a receptive audience amongst caregivers, patients, and technologists, and those who view the world of medicine as ripe for change,” said Velano Chief Executive Eric M. Stone. “Our vision is to positively impact every human being on the planet through a more compassionate, efficient and fiscally responsible approach to the most common invasive procedure performed in hospitals every day.”
This year, Fast Company editors and writers sought out groundbreaking businesses across 35 industries and every region. The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy.
To learn more about Velano and solutions for the world’s growing vascular access challenge, visit http://www.velanovascular.com.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies and thinkers on the future of business. Since 2011, Fast Company has received some of the most prestigious editorial and design accolades, including the American Society of Magazine Editors (ASME) National Magazine Award for “Magazine Of The Year,” Adweek’s Hot List for “Hottest Business Publication,” and six gold medals and 10 silver medals from the Society of Publication Designers. The editor-in-chief is Stephanie Mehta and the publisher is Amanda Smith. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication
Inc., and can be found online at www.fastcompany.com.
Press Contact:
Michael Azzano
Cosmo PR
michael@cosmo-pr.com
415-596-1978